Harrow (HROW) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Harrow (HROW) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 5.84% |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -11.73% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 7.65% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 0.86% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 27.15% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -6.48% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 11.32% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 11.90% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 28.35% |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 50.36 Mn | -6.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.60% |
| Mar 31, 2026 | -4.43% |
| Dec 31, 2025 | -2.21% |
| Sep 30, 2025 | 0.89% |
| Jun 30, 2025 | 7.95% |
| Mar 31, 2025 | 6.33% |
| Dec 31, 2024 | 5.93% |
| Sep 30, 2024 | -9.10% |
| Jun 30, 2024 | -12.67% |
| Mar 31, 2024 | -6.90% |
| Dec 31, 2023 | -3.08% |
| Sep 30, 2023 | -8.73% |
| Jun 30, 2023 | -10.06% |
| Mar 31, 2023 | -11.35% |
| Dec 31, 2022 | -13.44% |
| Sep 30, 2022 | -14.15% |
| Jun 30, 2022 | -22.27% |
| Mar 31, 2022 | -21.95% |
| Dec 31, 2021 | -21.02% |
| Sep 30, 2021 | -7.31% |